𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined treatment with biphosphonates, low-dose chemotherapy, and trastuzumab in receptor-negative breast cancer patients with bone marrow involvement

✍ Scribed by S Bezares; M.L Amador; D Castellano; J.M Trigo; H Cortés-Funes; R Colomer

Book ID
117644131
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
37 KB
Volume
12
Category
Article
ISSN
0953-6205

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Late intensification with high-dose melp
Late intensification with high-dose melphalan and autologous bone marrow support in breast cancer patients responding to conventional chemotherapy
✍ Mark D. Vincent; Trevor J. Powles; R. Charles Coombes; T. J. McElwain 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 557 KB

Fifteen patients with advanced breast cancer who had achieved either a good partial or a complete response to conventional chemotherapy were selected to receive intensification treatment with high-dose melphalan 140-200 mg/m2 (HDM). All patients received autologous bone marrow rescue. All patients e